ANiGENT

Want to achieve near 100% accuracy detecting drug diversion?

Most facilities say drug diversion or practice improvement events are often difficult to detect. Find out how 80+ facilities were able to achieve near 100% accuracy and significantly:

  • Improve patient outcomes
  • Strengthen operational efficiencies
  • Predict future behavior and risks
  • Identify a course of action

ANiGENT Vice President Matt Stone will present the only drug diversion solution in the market capable of near 100% accuracy.

What:



Who:


When:

Where:

How:

HCP Live Online Reverse Expo,

Summer Session 2022

ANiGENT VP, Business Development 

Matt Stone


June 20-24, 8 AM to 5 PM CST Daily

Online at HCP Website


Register at HCP Website

or Click the Button Below

Directors planning to attend the Reverse Expo can register online and schedule a meeting with Matt Stone. Those unable to attend can still watch an intro clip or sign up for a demo by clicking the button below.

About ANiGENT



ANiGENT was established in 2019 to deliver a comprehensive, patent-pending drug diversion detection platform: Medication Administration & Analysis Program (MAAP Analytics®). Built by clinicians for clinicians and backed by over 10 years of refine-ments in a clinical setting, MAAP Analytics uses machine learning to track all users, all medications, in all locations and identify the root cause of discrepancies in minutes. Purpose-built and proven to produce ac-tionable intelligence, MAAP Analytics is operationally efficient and configurable to any facility’s requirements.


ANiGENT

To Request a Demo: info@anigent.com

833-264-4368

© ANiGENT LLC | All Rights Reserved | Privacy Policy

Follow RXinsider on Social Media